loading
Schlusskurs vom Vortag:
$1.70
Offen:
$1.71
24-Stunden-Volumen:
1,001
Relative Volume:
0.13
Marktkapitalisierung:
$9.69M
Einnahmen:
$2.35M
Nettoeinkommen (Verlust:
$-2.56M
KGV:
-3.8899
EPS:
-0.4396
Netto-Cashflow:
-
1W Leistung:
-14.93%
1M Leistung:
-13.20%
6M Leistung:
-20.87%
1J Leistung:
-10.00%
1-Tages-Spanne:
Value
$1.71
$1.71
1-Wochen-Bereich:
Value
$1.70
$2.01
52-Wochen-Spanne:
Value
$1.59
$5.96

Immuron Limited Adr Stock (IMRN) Company Profile

Name
Firmenname
Immuron Limited Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
7
Name
Twitter
@ImmuronLtd
Name
Nächster Verdiensttermin
2024-08-27
Name
Neueste SEC-Einreichungen
Name
IMRN's Discussions on Twitter

Vergleichen Sie IMRN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IMRN
Immuron Limited Adr
1.71 9.69M 2.35M -2.56M 0 -0.4481
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
405.04 103.71B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
721.00 78.28B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
622.90 36.77B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
237.20 30.35B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
114.69 27.32B 3.30B -501.07M 1.03B -2.1146

Immuron Limited Adr Aktie (IMRN) Neueste Nachrichten

pulisher
Nov 21, 2024

Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event - GlobeNewswire Inc.

Nov 21, 2024
pulisher
Nov 18, 2024

Immuron to Present at Q4 Virtual Investor Summit: Gut Disease Pipeline Showcase | IMRN Stock News - StockTitan

Nov 18, 2024
pulisher
Oct 15, 2024

Immuron Travelan® continued strong sales growth - Quantisnow

Oct 15, 2024
pulisher
Oct 04, 2024

NMRC Reports Results for Campylobacter Controlled Human Infection Model Study - The Manila Times

Oct 04, 2024
pulisher
Sep 12, 2024

IMRNImmuron Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan

Sep 12, 2024
pulisher
Sep 06, 2024

Immuron: US FDA provides favourable feedback ahead of investigational new drug application for IMM-529 - Proactive Investors Australia

Sep 06, 2024
pulisher
Sep 05, 2024

Immuron Plans Phase 2 Trial for IMM-529 following FDA review - Markets Insider

Sep 05, 2024
pulisher
Sep 05, 2024

Immuron Plans Phase 2 Trial for IMM-529 following FDA review | Daily Guardian - Daily Guardian Canada

Sep 05, 2024
pulisher
Aug 16, 2024

Immuron secures new US DoD research award - Investing.com

Aug 16, 2024
pulisher
Aug 16, 2024

Immuron secures new US DoD research award By Investing.com - Investing.com Australia

Aug 16, 2024
pulisher
Jul 17, 2024

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now - GlobeNewswire Inc.

Jul 17, 2024
pulisher
Jul 15, 2024

Treasuries slip, dollar firm as markets grapple with US politics By Reuters - Investing.com

Jul 15, 2024
pulisher
Jul 05, 2024

Curtiss Wright CEO Lynn M Bamford buys $10.2k in stock By Investing.com - Investing.com India

Jul 05, 2024
pulisher
Jul 05, 2024

Immuron CEO to present at Sharewise investor event By Investing.com - Investing.com

Jul 05, 2024
pulisher
Jul 03, 2024

Immuron to raise up to $2M as part of an ATM equity offering (NASDAQ:IMRN) - Seeking Alpha

Jul 03, 2024
pulisher
Jul 02, 2024

Immuron secures around US$2 million in funding after lodging Form F-3 and ATM prospectus with US SEC By ... - Investing.com

Jul 02, 2024
pulisher
Jul 02, 2024

Immuron requests pre-IND meeting for IMM-529 with FDA filing - Markets Insider

Jul 02, 2024
pulisher
Jul 01, 2024

Immuron files pre-investigational new drug US FDA application for superbug fighting IMM-529 - Proactive Investors Australia

Jul 01, 2024
pulisher
Apr 10, 2024

Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Markets Insider

Apr 10, 2024
pulisher
Mar 08, 2024

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.34% - Investing.com India

Mar 08, 2024
pulisher
Mar 07, 2024

Immuron stock surges after mid-stage data for Travelan - Seeking Alpha

Mar 07, 2024
pulisher
May 16, 2023

Immuron Limited Announces Participation in the LD Micro Invitational XIII - The Kingston Whig-Standard

May 16, 2023
pulisher
Jan 25, 2023

Immuron US DoD Naval Medical Research Center responds to - GlobeNewswire

Jan 25, 2023
pulisher
Feb 03, 2020

Immuron’s Technology Platform of Treatments in the Age of the Coronavirus Outbreak - GlobeNewswire

Feb 03, 2020
pulisher
Jun 27, 2018

Immuron Limited Trade Ideas — NASDAQ:IMRN - TradingView

Jun 27, 2018
pulisher
Mar 08, 2018

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.33% - Investing.com

Mar 08, 2018
pulisher
Mar 07, 2018

Immuron Limited Issues Correction to Misleading Halt Announcement Headline - GlobeNewswire

Mar 07, 2018
pulisher
Jan 31, 2016

Pharma & Biotech - Proactive Investors USA

Jan 31, 2016

Finanzdaten der Immuron Limited Adr-Aktie (IMRN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.87
price up icon 0.48%
$69.86
price up icon 1.16%
$352.84
price down icon 1.34%
$41.87
price down icon 0.11%
$184.71
price up icon 0.49%
$114.95
price up icon 0.96%
Kapitalisierung:     |  Volumen (24h):